Research evaluating the utility of insulin therapy for AD and PD is underway
Relation of weight loss to changes in serum lipids and lipoproteins in obese women
Ideal for sensitive digestive systems
GLP-1s may not be suitable for people who: Have a history of pancreatitis Have certain thyroid conditions (e.g., medullary thyroid cancer) Are pregnant or breastfeeding (depending on the specific medication) Have severe gastrointestinal conditions, like gastroparesis GLP-1 receptor agonists, including Tirzepatide, have been shown to lead to significant weight loss, with many people losing 10-15% of their body weight over time
May 1, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Therapies, Type 2 Diabetes, Type 2 Diabetes 4,269 views Why do some patients see impressive results with GLP-1 therapies while others barely respond
2016, p